These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19571557)

  • 1. Plasma visfatin concentrations in subjects with type 1 diabetes mellitus.
    Toruner F; Altinova AE; Bukan N; Arslan E; Akbay E; Ersoy R; Arslan M
    Horm Res; 2009; 72(1):33-7. PubMed ID: 19571557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes.
    Zhu J; Schott M; Liu R; Liu C; Shen B; Wang Q; Mao X; Xu K; Wu X; Schinner S; Papewalis C; Scherbaum WA; Liu C
    Horm Metab Res; 2008 Nov; 40(11):801-5. PubMed ID: 18686225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy.
    Rezvan N; Hosseinzadeh-Attar MJ; Masoudkabir F; Moini A; Janani L; Mazaherioun M
    Arch Gynecol Obstet; 2012 May; 285(5):1257-62. PubMed ID: 22167446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in plasma apelin and visfatin levels between patients with type 1 diabetes mellitus and healthy subjects and response after acute hyperglycemia and insulin administration.
    Alexiadou K; Kokkinos A; Liatis S; Perrea D; Katsilambros N; Tentolouris N
    Hormones (Athens); 2012; 11(4):444-50. PubMed ID: 23422767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans.
    Marcinkowska M; Lewandowski KC; Lewiński A; Bieńkiewicz M; Basińska-Lewandowska M; Salata I; Randeva HS
    Endokrynol Pol; 2007; 58(3):188-94. PubMed ID: 17940983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of visfatin in type 2 diabetes patients with diabetic kidney disease: Relationship to inflammation, adiposity and undercarboxylated osteocalcin.
    Kacso AC; Bondor CI; Coman AL; Potra AR; Georgescu CE
    Scand J Clin Lab Invest; 2016; 76(3):217-25. PubMed ID: 26922969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of serum visfatin and metabolisms of glucose and lipid in women with gestational diabetes mellitus.
    Liang Z; Wu Y; Xu J; Fang Q; Chen D
    J Diabetes Investig; 2016 Mar; 7(2):247-52. PubMed ID: 27042278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus.
    Erdem G; Dogru T; Tasci I; Bozoglu E; Muhsiroglu O; Tapan S; Ercin CN; Sonmez A
    Diabetes Res Clin Pract; 2008 Nov; 82(2):214-8. PubMed ID: 18778865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus.
    Akbarzadeh S; Nabipour I; Jafari SM; Movahed A; Motamed N; Assadi M; Hajian N
    Diabetes Res Clin Pract; 2012 Jan; 95(1):132-8. PubMed ID: 22024288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester.
    Akturk M; Altinova AE; Mert I; Buyukkagnici U; Sargin A; Arslan M; Danisman N
    J Endocrinol Invest; 2008 Jul; 31(7):610-3. PubMed ID: 18787378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.
    Li L; Yang G; Li Q; Tang Y; Yang M; Yang H; Li K
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):544-8. PubMed ID: 17177135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum visfatin increases with progressive beta-cell deterioration.
    López-Bermejo A; Chico-Julià B; Fernàndez-Balsells M; Recasens M; Esteve E; Casamitjana R; Ricart W; Fernández-Real JM
    Diabetes; 2006 Oct; 55(10):2871-5. PubMed ID: 17003355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum visfatin concentration is elevated in pregnant women irrespectively of the presence of gestational diabetes.
    Szamatowicz J; Kuźmicki M; Telejko B; Zonenberg A; Nikołajuk A; Kretowski A; Górska M
    Ginekol Pol; 2009 Jan; 80(1):14-8. PubMed ID: 19323054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease.
    Pfützner A; Marx N; Walcher D; Löbig M; Seidel D; Forst T
    Clin Lab; 2008; 54(7-8):237-41. PubMed ID: 18942491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus.
    El-Mesallamy HO; Kassem DH; El-Demerdash E; Amin AI
    Metabolism; 2011 Jan; 60(1):63-70. PubMed ID: 20605615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of maternal serum resistin and visfatin levels with gestational diabetes mellitus.
    Karatas A; Tunçay Işikkent N; Ozlü T; Demirin H
    Gynecol Endocrinol; 2014 May; 30(5):355-8. PubMed ID: 24512558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].
    Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breastfeeding effects on visfatin levels in postpartum women.
    Shen CJ; Wang SH; Lee CH; Chan TF
    Taiwan J Obstet Gynecol; 2015 Jun; 54(3):217-20. PubMed ID: 26166329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.
    Jian WX; Luo TH; Gu YY; Zhang HL; Zheng S; Dai M; Han JF; Zhao Y; Li G; Luo M
    Diabet Med; 2006 Sep; 23(9):967-73. PubMed ID: 16922702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.